- Acquired by Janssen, Pharmaceutical Company Of Johnson & Johnson on June 28, 2012
- Funding Received
- $879.6 Thousand in 1 Round from 2 Investors
Corimmun is a clinical drug developing company located in Martinsried near Munich, Germany, and is focused on novel therapeutics and diagnostics for heart and vascular diseases. Corimmun's activities and experiences comprise all steps from research to drug development and commercialization.
Lochhamer Str. 29; RÃ¼ckgebÃ¤ude